Contact Us News RSS Login

Harvard Catalyst - The Harvard Clinical and Translational Science Center
  1. People
    1. Overview
    2. Grant Central
    3. Medvane
    4. Profiles
  2. Learning
    1. Overview
    2. Colloquium Series
    3. Conferences and Seminars
    4. Dean's Symposium
    5. Leder Human Biology
    6. Biomedical Informatics Training
    7. Biostatistics Training
    8. Clinical Investigator Training Program
    9. Scholars in Clinical Science
    10. KL2 Medical Research Investigator Training
    11. Introduction to Clinical Investigation
    12. Biostatistics Seminar Series
    13. Genetics Courses
    14. Imaging Courses
  3. Resources
    1. Overview
    2. Pilot Funding
    3. AEGIS Influenza
    4. Atlas
    5. Community-Based Participatory Research
    6. Community Connect to Research
    7. Consulting Programs
    8. Core Facilities
    9. HarvardTrials
    10. Health Disparities Research Program
    11. In/Outpatient Resources
    12. Laboratory for Innovative Translational Technologies
    13. Law and Health Policy
    14. Medications and Society
    15. Pathology Specimen Locator
    16. SHRINE
    17. Webdash
Find
People

Profiles

Read About Profiles -- the Harvard Catalyst's social networking site.
Find information about people's institutions in the Atlas.

Julie Lin, M.D.

 
Title
Assistant Professor of Medicine
Institution
Brigham and Women's Hospital
Department
Medicine
Division
Renal
Address
Brigham and Women's Hospital
Renal
75 Francis St
Boston, MA 02115
Telephone
617/732-6432
Fax
617/975-0840
Email
Email Address
Publications
1. Mayer SA, LIN J, Homma S, Solomon RA, Lennihan L, Sherman D, Fink ME, Beckford A, Kebanoff LM . Myocardial injury and left ventricular performance after subarachnoid hemorrhage. Stroke. 1999; 30(4):780-786..
2. Kambham N, Markowitz GS, Valeri AM, LIN J, D’Agati VD. Obesity-related glomerulopathy: an emerging epidemic. Kidney Int. 2001; 59(4):1498-1509..
3. LIN J, Markowitz GS, Valeri AM, Kambham N, Sherman WH, Appel GB, D’Agati VD. Monoclonal immunoglobulin deposition disease: the disease spectrum. J Am Soc Nephrol. 2001; 12(7):1482-1492..
4. LIN J, Markowitz GS, Nicolaides M, D’Agati VD. A 76 year old woman with nephrotic syndrome. Am J Kid Dis. 2001; 38(2):437-440.
5. LIN J, Markowitz GS, Nicolaides M, Hesdorffer CS, Appel GB, D’Agati VD, Savage DG. Membranous glomerulopathy associated with graft-versus-host disease following allogeneic stem cell transplantation. Am J Nephrol. 2001; 21(5):351-356..
6. LIN J, Valeri AM, Markowitz GS, D’Agati VD, Cohen DJ, Radhakrishnan J . Angiotensin converting enzyme inhibition in chronic renal allograft nephropathy. Transplantation. 2002; 73(5):783-788..
7. Markowitz GS, LIN J, Valeri AM, Avila C, Nasr SH, D’Agati VD. Idiopathic nodular glomerulosclerosis is a distinct entity linked to hypertension and smoking. Hum Pathol. 2002; 33(8):826-835..
8. LIN J, David FS, Valeri AM, Barisoni L, Markowitz GS, D’Agati VD. The changing epidemiology of focal segmental glomerulosclerosis (FSGS): a 28-year single center study. J Am Soc Nephrol. 2002; 13:452A.
9. LIN J, Markowitz GS, Valeri AM, Kambham N, Sherman W, Appel GB, D’Agati VD. Renal monoclonal immunoglobulin deposition disease (MIDD). Monoclonal Gammopathies and the Kidney (Guy Touchard, Pierre Aucouturier, Olivier Hermine, and Pierre Ronco, Editors). 2003; 130-144.
10. Lin J, Knight EL, Hogan ML, Singh AK. A comparison of prediction equations for estimating glomerular filtration rate in adults without kidney disease. J Am Soc Nephrol. 2003 Oct; 14(10):2573-80.
11. LIN J, Knight EL, Hogan ML, Singh AK. A comparison of prediction equations for estimating glomerular filtration rate in adults without kidney disease. J Am Soc Nephrol. 2003; 14(10):2573-2580..
12. Crew RJ, David FS, Rubel J, Valeri AM, Barisoni L, Markowitz GS, Appel GB, D’Agati VD, LIN J. Medical therapy and long-term renal outcomes of focal segmental glomerulosclerosis (FSGS). J Am Soc Nephrol. 2003; 14:526A.
13. Leacche M, Rawn JD, Mihaljevic T, Lin J, Karavas AN, Paul S, Byrne JG. Outcomes in patients with normal serum creatinine and with artificial renal support for acute renal failure developing after coronary artery bypass grafting. Am J Cardiol. 2004 Feb 1; 93(3):353-6.
14. Leacche M, Rawn JD, Mihaljevic T, LIN J, Karavas AN, Paul S, Byrne JG. Outcomes in patients with normal serum creatinine and with artificial renal support for acute renal failure developing after coronary artery bypass grafting. Am J Cardiol. 2004; 93:353-356..
15. Stokes MB, Markowitz GS, LIN J, Valeri AM, D’Agati VD. Glomerular tip lesion: a distinct entity within the minimal change/focal segmental glomerulosclerosis spectrum. Kidney Int. 2004; 65(5):1690-1702..
16. Forman JP, Tinckam K, LIN J, Cosimi B, Tolkoff-Rubin N. T-Cell depleting induction therapy and risk of acute humoral allograft rejection. J Am Soc Nephrol. 2004; 15:297A.
17. Henderson J, Hegedus A, LIN J, Rennke H, Chandraker A. Relevance of thrombotic microangiopathy in native nephrectomy specimens obtained at time of transplantation. J Am Soc Nephrol. 2004; 15:885A.
18. Forman JP, LIN J, Pascual M, Denton MD, Tolkoff-Rubin N. Significance of anticardiolipin antibodies and short and long-term graft survival and function following kidney transplantation. Am J Transplantation. 2004; 4(11):1786-91..
19. Forman JP, Lin J, Pascual M, Denton MD, Tolkoff-Rubin N. Significance of anticardiolipin antibodies on short and long term allograft survival and function following kidney transplantation. Am J Transplant. 2004 Nov; 4(11):1786-91.
20. Wong W, Denton M, Rennke HG, Lin J. Hepatitis C, proteinuria, and renal insufficiency. Am J Kidney Dis. 2004 Nov; 44(5):924-9.
21. Wong W, Denton M, Rennke HG, LIN J. Hepatitis C, proteinuria, and renal insufficiency. Am J Kidney Diseases. 2004; 44(5):924-929.
22. Forman JP, Tolkoff-Rubin N, Pascual M, LIN J . Hepatitis C, acute humoral rejection, and renal allograft survival. J Am Soc Nephrol. 2004; 15(12):3249-55..
23. Forman JP, Tolkoff-Rubin N, Pascual M, Lin J. Hepatitis C, acute humoral rejection, and renal allograft survival. J Am Soc Nephrol. 2004 Dec; 15(12):3249-55.
24. Lin J, August P. Genetic thrombophilias and preeclampsia: a meta-analysis. Obstet Gynecol. 2005 Jan; 105(1):182-92.
25. LIN J, August P. Genetic thrombophilias and pre-eclampsia: a meta-analysis. Obstet Gynecol. 2005; 105(1):182-192..
26. Lin J, Bonventre JV. Prevention of radiocontrast nephropathy. Curr Opin Nephrol Hypertens. 2005 Mar; 14(2):105-10.
27. LIN J, Bonventre JV. Prevention of radiocontrast nephropathy. Curr Opin Nephrol Hyperten. 2005; 14(2):105-10.
28. Frisch G, LIN J, Rosenstock J, Markowitz G, D’Agati V, Radhakrishnan J, Preddie D, Crew J, Valeri A, Appel G. Mycophenolate mofetil vs. placebo in patients with moderately advanced IgA nephropathy: a double-blind randomized controlled trial . Nephro Dial Transplant. 2005; 20(10):2139-45..
29. LIN J, Hu FB, Qi L, Curhan GC. Angiotensin Type 1 Receptor and Angiotensinogen Polymorphisms and Risk of Hypertension, Cardiovascular Disease, and Renal Dysfunction in Type 2 Diabetes. J Am Soc Nephrol. 2005; 16:554A.
30. LIN J, Hu FB, Qi L, Curhan GC. Associations of Serum Adiponectin, Adiponectin Polymorphisms, and Renal Dysfunction in Type 2 Diabetes Mellitus. J Am Soc Nephrol. 2005; 16:338A.
31. LIN J, Hu FB, Rifai N, Rimm E, Curhan GC. The association of serum lipids and inflammatory biomarkers with renal function in men with type 2 diabetes mellitus. Kidney Int. 2006; 69(2):336-42..
32. Leacche M, Winkelmayer WC, Paul S, LIN J, Unic D, Rawn JD, Cohn LH, Byrne JG. Predicting survival in patients requiring renal replacement therapy after cardiac surgery. Ann Thoracic Surg. 2006; 81:1385-92..
33. Leacche M, Winkelmayer WC, Paul S, Lin J, Unic D, Rawn JD, Cohn LH, Byrne JG. Predicting survival in patients requiring renal replacement therapy after cardiac surgery. Ann Thorac Surg. 2006 Apr; 81(4):1385-92.
34. LIN, J. Focal Segmental Glomerulosclerosis. Nephrology Rounds. 2006; 8(5).
35. LIN J, Solomon SD. Renal insufficiency as an independent risk factor for cardiovascular events. Heart Disease, 7th Edition (on-line), ed. Eugene Braunwald. 2006; ((in press)).
36. LIN J, Hu FB, Curhan GC. Antioxidant vitamins and renal dysfunction in type 2 diabetes mellitus. J Am Soc Nephrol. 2006; 17:156A.
37. Lin J, Hu FB, Curhan G. Serum adiponectin and renal dysfunction in men with type 2 diabetes. Diabetes Care. 2007 Feb; 30(2):239-44.
38. van der Zee S, Thompson A, Zimmerman R, LIN J, Huan Y, Braskett M, Sciacca RR, Landry DW, Oliver JA. Vasopressin administration facilitates fluid removal during hemodialysis. Kidney Int. 2007; 71(4):318-24.
39. LIN J, Hu FB, Curhan GC. Adiponectin and renal dysfunction in type 2 diabetes mellitus. Diabetes Care. 2007; 30(2):239-44.
40. Owens CD, Ho KJ, Kim S, Schanzer A, LIN J, Matros E, Belkin M, Conte MS. Refinement of survival prediction in patients undergoing lower extremity bypass surgery: stratification by chronic kidney disease classification. J Vasc Surg. 2007; 45(5):944-52.
41. Owens CD, Ho KJ, Kim S, Schanzer A, Lin J, Matros E, Belkin M, Conte MS. Refinement of survival prediction in patients undergoing lower extremity bypass surgery: stratification by chronic kidney disease classification. J Vasc Surg. 2007 May; 45(5):944-52.
42. LIN J, Manson JE, Schaumberg D. Inflammation and Progressive Nephropathy in the Diabetes Complication and Control Trial (DCCT). J Am Soc Nephrol. 2007; 18:325A.
43. Sadlier DM, Swami A, LIN J. A Meta-Analysis of the Association between Polymorpisms of the Angiotensin-2, Type 1 Receptor A1166C and Essential Hypertension. J Am Soc Nephrol. 2007; 18:606A.
44. Solomon SD, Lin J, Solomon CG, Jablonski KA, Rice MM, Steffes M, Domanski M, Hsia J, Gersh BJ, Arnold JM, Rouleau J, Braunwald E, Pfeffer MA. Influence of albuminuria on cardiovascular risk in patients with stable coronary artery disease. Circulation. 2007 Dec 4; 116(23):2687-93.
45. Solomon SD, LIN J*, Solomon CG, Jablonski KA, Rice MM, Steffes M, Domanski M, Hsia J, Gersh BJ, Arnold JMO, Rouleau J, Braunwald E, and Pfeffer MA, for the Prevention of Events with ACE Inhibition (PEACE) Investigators. The influence of albuminuria on cardiovascular risk in patients with stable coronary artery disease. Circulation. 2007; 116(23):2687-2693 (*co-first author).
46. Weinrauch LA, Lin J, Solomon SD. Mapping directions for the cardiorenal conundrum: where you end up depends upon where you started, so where do we go from here? J Am Coll Cardiol. 2008 Apr 1; 51(13):1275-6.
47. Weinrauch LA, LIN J, Solomon SD. Mapping directions for the cardiorenal conundrum: where you end up depends upon where you started, so where do we go from here?. J Am Coll Cardiol. 2008; 51(13):1268-74.
48. LIN J, Curhan GC. Kidney function decline and physical function in women. Neph Dial Transpl. 2008; 23:2827-33.
49. Hunt JL, LIN J. Paroxysmal hypertension in a 48-year-old woman. Kidney Int. 2008; 74(4):532-5.
 
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact Human Resources at faculty_serviceshms.harvard.edu.